12/19
04:05 pm
lfwd
Lifeward Appoints Bob Marshall as Chairman of the Board
Medium
Report
Lifeward Appoints Bob Marshall as Chairman of the Board
12/17
08:00 am
lfwd
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
Low
Report
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
12/3
08:00 am
lfwd
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
High
Report
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
11/18
08:03 am
lfwd
Lifeward (NASDAQ:LFWD) had its price target lowered by analysts at HC Wainwright from $13.00 to $4.50. They now have a "buy" rating on the stock.
Low
Report
Lifeward (NASDAQ:LFWD) had its price target lowered by analysts at HC Wainwright from $13.00 to $4.50. They now have a "buy" rating on the stock.
11/17
08:00 am
lfwd
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
Medium
Report
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
11/14
08:00 am
lfwd
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
Medium
Report
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
11/10
07:00 am
lfwd
Lifeward to Report Third Quarter Financial Results on November 14, 2025
Low
Report
Lifeward to Report Third Quarter Financial Results on November 14, 2025